Potassium bromate (KBrO3) is an oxidizing agent that has been used as a food additive, mainly in the bread-making process. Although adverse effects are not evident in animals fed bread-based diets made from flour treated with KBrO3, the agent is carcinogenic in rats and nephrotoxic in both man and experimental animals when given orally. It has been demonstrated that KBrO3 induces renal cell tumors, mesotheliomas of the peritoneum, and follicular cell tumors of the thyroid. In addition, experiments aimed at elucidating the mode of carcinogenic action have revealed that KBrO3 is a complete carcinogen, possessing both initiating and promoting activities for rat renal tumorigenesis. However, the potential seems to be weak in mice and hamsters. In contrast to its weak mutagenic activity in microbial assays, KBrO3 showed relatively strong potential inducing chromosome aberrations both in vitro and in vivo. Glutathione and cysteine degrade KBrO3 in vitro; in turn, the KBrO3 has inhibitory effects on inducing lipid peroxidation in the rat kidney. Active oxygen radicals generated from KBrO3 were implicated in its toxic and carcinogenic effects, especially because KBrO3 produced 8-hydroxydeoxyguanosine in the rat kidney. A wide range of data from applications of various analytical methods are now available for risk assessment purposes.
Introduction
In the mid-1970s, the close correlation between mutagenicity and carcinogenicity of many chemicals became striking to those engaged in studies on carcinogenesis. Accordingly, a cooperative program was designed to evaluate the predictability of mutagenicity tests for carcinogenicity. This program commenced in 1974 under the auspices of the Ministry of Health and Welfare of Japan (1, 2) . To date, 85 bioassays using rats and/or mice have been conducted on 51 chemicals, including medical drugs, pesticides, and food additives.
KBrO3 was selected as one of the chemicals for carcinogenicity testing because of its positive mutagenicity and widespread use as a food additive. It is used mainly in the maturation process offlour because ofits oxidizing properties. In 1978, long-term bioassays of KBrO3 were started by using rats and mice; as a result, this oxidizing agent was found to be carcinogenic in rats after 2 years of oral administration (3) .
The present review covers the various toxicological studies that have mainly been conducted in our laboratory (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) , with the aim of elucidating the mode of action and mechanisms of KBrO3 carcinogenicity. The International Agency for Research on Cancer (IARC) recently evaluated all of the data on KBrO3 and concluded, "There is sufficient evidence for the carcinogenicity of KBrO3 in experimental animals. No data were available on the carcinogenicity of KBrO3 to humans" (20) . KBrO3 has been also classified as a compound belonging to the group 2B, a possible human carcinogen (21) .
Chemistry and Use
Since this paper is primarily intended as a review of biological data on KBrO3, we encourage readers to refer to the International Agency for Research on Cancer (IARC) Monograph for further details on the subjects covered in this chapter (20) .
Chemistry and Production
Potassium bromate (KBrO3, CAS No. 7758-01-2, molecular weight 167.01; density, 3.27) exists as white crystals, crystalline powder, or granules. It is highly soluble in water (7.5 g/100 mL at 25°C; 49.8 g/100 mL at 100°C), slightly soluble in ethanol, and almost insoluble in acetone; it is very stable when dissolved in water at room temperature. KBrO3 decomposes at temperatures above 370°C (melting point: 350°C), with the evolution of oxygen and toxic fumes containing potassium oxide and BrK; it reacts vigorously as a strong oxidizing agent with organic materials.
KBrO3 can be produced by passing bromine through a solution of potassium hydroxide. However, the compound is manufactured mainly by large-scale industrial electrolytic processes.
Occupational exposure to KBrO3 occurs mainly in production plants during packaging processes in which areas in excess of 100 mg/m3 require the use of a dust respirator.
Use
KBrO3 has been used primarily as a maturing agent for flour and as a dough conditioner in the bread-making process for over 50 years (22) (23) (24) , and this application is now used worldwide. Food additive-grade KBrO3 is specified to contain KBrO3 at levels of 99 .0 to 101.0% after drying. In Japan, allowable limits are specified to be no more than 4 ppm for arsenic and heavy metals and 10 ppm for lead. The levels of contaminants in KBrO3 used in our studies were within an acceptable range (6) .
The Joint Food and Agricultural Organization (FAO)/ World Health Organization Expert Committee on Food Additives (JECFA) has temporarily recommended a maximum level of 75 ppm of KBrO3 for treating flour, provided that baking products prepared from such treated flour contain negligible residues of KBrO3 (25) 
In Japan, the level has been set at 30 ppm under the same conditions as for JECFA (26) . The effects of KBrO3 on various nutritional values of the flour are reported to be negligible (22) .
In the past, especially in Japan, KBrO3 was used to improve the quality of fish-paste products (Kamaboko) at concentrations less than 270 mg/kg. However, this application of KBrO3 is no longer allowed (26) .
As nonfood usage, KBrO3 has been introduced as an oxidizing agent, a primary standard, and a brominating agent in analytical chemistry. Its oxidizing property has further been used in home permanent-wave neutralizing compounds at concentrations of between 5 to 25% at pH 4 to 9, together with sodium bromate, sodium perborate, or hydrogen peroxide (27) .
Analysis
KBrO3 can be determined by iodometric titration methods, photometric ion chromatography (28) (29) (30) (31) , and by high-performance liquid chromatography (HPLC) (32) . In Great Britain levels of KBrO3 in bread assessed by the iodometric titration method were negligible when the dough was treated with KBrO3 < 50 ppm (33, 34) . Furthermore, bromate could not be detected by ion chromatography in bread treated with < 50 ppm of KBrO3 (28) . Recently it was reported that the detection limit of a newly developed HPLC method, based on the formation of triiodide ion by the reduction of bromate and iodide (0.05 ppm) (32) , is much lower than that detected by ion chromatography (1 ppm) (29) . However, bromate was not detected in 10 samples of commercial bread in Japan by this very sensitive approach (32) .
Toxicity Acute Toxicity in Experimental Animals
Groups of five males and five females each of F344 rats, B6C3F1 mice, and Syrian golden hamsters were given a single intragastric (IG) administration of KBrO3 and observed for 7 days (9) . In all species given high doses (900-700 mg/kg of body weight), two-thirds of the animals died within 3 hr of the treatment; the remaining one-third survived up to 48 hr. Major toxic signs and symptoms observed were animals lying in a prone position, suppression of locomotor movement, ataxic gait, tachypnea, hypothermia, diarrhea, lacrimation, and piloerection. At autopsy the major findings were strong hyperemia of the glandular stomach mucosa and congestion of the lung. Microscopically, epithelial dilatation and desquamation of the distal convoluted tubules were noted in rats as early as 1 hr after KBrO3 administration. Necrosis and degenerative changes of the proximal tubular epithelium were observed after 3 hr, and regenerative changes of the tubular epithelium occurred within 48 hr, becoming more extensive after 2 weeks. In mice and hamsters, however, these histological changes were observed later and to a lesser degree. No glomerular lesions were found in any of the species examined.
LD50 values calculated by the Probit method are shown in Table 1 . Although LD50 values were higher in females than in males in all species examined, there were no marked species differences. The fact that the values were distributed in the range of around 300 to 500 mg/kg of body weight in all three species implies that KBrO3 should be classified as a very toxic chemical. Furthermore, in Wistar rats the LD50 values for both sexes were reportedly to be approximately 160 to 180 mg/kg body weight (Kawachi, personal communication) .
An increase in the levels of cholesterin and phospholipids was observed in the brain and kidney in mice after a single IG administration of KBrO3 (35) .
Acute Toxicity in Humans
Case reports on KBrO3 poisoning in humans are not uncommon because of the widespread use of the compound in home permanent-waving kits. However, there seem to be different geographical trends in occurrence. In Western countries most poison cases are by acciden- (37) . In reported cases the actual amount ingested ranged from 12 to 50 g, and 9 out of 24 adults died 3 to 5 days after ingestion (35, 37) .
In the acute phase ofpoisoning, vomiting and diarrhea with abdominal pain are the main symptoms. Subsequent features include oliguria, anuria, deafness, vertigo, hypotension, depression of the central nervous system, and thrombocytopenia. Clinically, acute renal failure is evidenced by the impairment of various renal functions and an associated development of hemolytic uremic syndrome (36) . On biopsy of the kidney atrophy, necrosis, degeneration, and regeneration of the proximal tubular epithelium have often been reported. In the later stages, however, sclerosis of the glomeruli and interstitial fibrosis become evident; cardiotoxicity and hepatotoxicity have also been reported (37 Ototoxicity of KBrO3 and NaBrO3 was studied in guinea pigs after IP injection at a daily dose of 10 to 20 mg/kg body weight for 10 to 20 days (41) . Histologically, degeneration of the cochlear sensory cells, particularly of the outer hair cells of the inner ear was observed. At the same time, nephrotoxic effects of KBrO3 and NaBrO3 were also confirmed in guinea pigs. The fact that the kidney and the inner ear are both highly efficient systems for transport of water and electrolytes might explain the coincidental occurrence ofnephro-and ototoxicity by these chemicals (40) .
Subacute Toxicity
Administration of KBrO3 in Drinking Water of Mice. Groups of 10 male and 10 female B6C3F1 mice were given KBrO3 at doses of 4000, 2000, 1000, 500 and 250 ppm for 10 weeks (15) . Doses > 2000 ppm were not palatable. No treatment-associated deaths of animals given < 1000 ppm or particular histopathological changes attributed to KBrO3 administration were observed. 13 weeks. A significant inhibition of body weight increase was observed in males given 1250 or 600 ppm. Significantly elevated levels of GOT, GPT, LDH, ALP, BUN, serum-Na and Ch-E were noted in rats of both sexes given 600 ppm. Serum-K levels were also significantly decreased. Many various-sized droplets stained strongly with eosin were observed in the cytoplasm of the proximal tubular epithelium in treated males. Extensive regenerative changes were seen in the renal tubules.
For analyzing the droplets observed in the renal tubules, groups of five male F344 rats were given 600 ppm KBrO3 orally for 12 weeks (10). In renal tubules, various-sized droplets were found as early as 4 weeks after the treatment began (Fig. 1) . The incidence of the droplets decreased to control levels 4 weeks after terminating the treatment. These droplets were positive for Azan, negative for PAS, and partially positive for hemoglobin staining; they were also observed in control rats, though to a far lesser degree. As observed by electron microscopy, the droplets demonstrated high electron density and were surrounded by a limiting membrane layer (Fig. 2) . The origin of these droplets seemed to be the lysosomes, and they seemed to result from material being reabsorbed. From the morphological characteristics, it was concluded that these droplets were eosinophilic bodies rather than hyaline droplets (42, 43) . Recently, droplets showing similar characteristics were observed in the kidneys of rats given decalin, 2,2,4-trimethylpentane, or unleaded gasoline. In these cases, however, they were classified as hyaline droplets (44, 46) . U2u-Globulin, which is specific for the kidneys of male rats, seems to be involved in the appearance of the hyaline droplets. In preliminary studies the gen- 
Multigeneration Studies
Bread made from flour treated with 14 or 100 ppm of KBrO3 was fed to groups of 6 male and 20 female rats over three generations; the entire experiment lasted 10 months (22) . The health, behavior, weight gain, and reproductive performance remained normal throughout. There were no histological abnormalities and analyses of the brain and the liver showed no accumulation of bromine.
Mice and rats (numbers were not specified) were fed flour treated with 15 
Studies in Japan
After learning about the United Kingdom's results on long-term studies in which animals were fed a bread basal diet prepared from KBrO3-treated flour, we became interested in the possible carcinogenicity of the chemical. Hence, KBrO3 was given to animals by oral administration as a drinking water supplement at high concentrations, the highest doses being the maximum tolerated doses. Detailed protocols for the experiments have been described (3) (4) (5) (6) (8) (9) (10) (13) (14) (15) .
Carcinogenicity Tests in Rats (3, 4, 6, 9, 15) . Groups of 53 males and 53 females of F344 rats received KBrO3 for 110 weeks at concentrations of 500 and 250 ppm in the drinking water. However, for males treated at the 500 ppm level, the dose was reduced to 400 ppm at week 60, because exposure to 500 ppm caused too great an inhibition of growth.
Dead or moribund rats were found earlier among males given 500 ppm than in other groups. Mean survival time in males given 500 ppm (88.1 weeks) was significantly shorter than that in controls (104.5 weeks). In females, the survival rates of treated and control groups were very similar. Daily intakes of KBrO3 (mg/kg body weight) were 27.7 and 12.5 in males and 25.5 and 12.5 in females in the high-and low-dose groups, respectively.
We suspected the kidney to be the target organ during the observational period by preliminary histological examination. Therefore, 10 to 15 step-serial sections were examined from each kidney. This procedure is not routine for pathological assessment in carcinogenicity studies. The results were high incidences of renal cell tumors (RCTs) in dosed males and females. Data for separated and combined incidences of renal adenocarcinomas and adenomas are summarized in Table 4 . Significant increases were evident for both sexes, as compared to the control group values. The incidences of RCT on the basis of routine microscopic examinations, in which one slide per kidney was checked, also showed significant differences from those of controls (i.e., 56, 30, and 2% in males; and 40, 10, and 0% in females given 500, 250, and 0 ppm KBrO3, respectively, p < 0.01, except in females given 250 ppm), as shown in our first report (3) . Although lesions were found much earlier in high-dose males than they were in the other groups, RCTs did not appear to be the main cause of death in the experiment. Dysplastic foci (DF), which are preneoplastic lesions for RCT, were observed in almost all of the treated rats of both sexes. Other tumors found in the kidney were two transitional cell papillomas, two transitional cell carcinomas, and one angiosarcoma in treated rats and one liposarcoma in a control rat. Tumors of the peritoneum, all diagnosed as mesotheliomas, also occurred at a significantly higher incidence in male rats given 250 or 500 ppm than in the controls (Table 5 ). On the other hand, no mesotheliomas were observed in either treated or control female rats. The mesotheliomas usually resulted in implantation onto the surfaces of various abdominal organs, with massive hemorrhagic ascites causing severe anemia leading to early death. Findings of nonneoplastic lesions of the kidney are described in the section "Pathological Lesions of the Kidney after KBrO3 Administration."
Significantly decreased values were found in GPT, the albumin/globulin (A/G) ratio, serum K, and Ch-E in females that were treated with 500 ppm KBrO3. Also, we noted that BUN levels were slightly increased in treated rats. There were no significant differences in the red blood cell (RBC) counts.
We concluded from the above findings that clear evi- 
aMales and females surviving longer than 14 and 85 weeks, respectively, when the earliest RCTs were found. p < 0.001. tp < 0.01. dence exists that when KBrO3 is given orally in drinking water, it is carcinogenic in rats of both sexes. Dose-Response Studies in the Rat (14) . Based on the results of the carcinogenicity test in rats, studies at low doses were conducted to further characterize the dose-response relationship (14) . Groups of 20 to 24 male F344 rats were given KBrO3 orally at concentrations of 500, 250, 125, 60, 30, 15, and 0 ppm for 104 weeks.
As in the previous carcinogenicity test, the mean survival time of the animals given 500 ppm (82.8 weeks) was significantly shorter than that of controls (103.1 weeks). However, at doses of 250 ppm or lower, the survival rates were comparable in treated and control groups and inhibition of body weight gain was not apparent.
Renal adenocarcinomas developed in 3 of the 20 rats given 500 ppm (Table 6) , and the incidences of renal adenomas and RCTs were significantly elevated in rats receiving concentrations of 500, 250, and 125 ppm. A sigmoidal curve was obtained when the incidences of RCTs were plotted against the dose of KBrO3 (Fig. 3) . Furthermore, significant dose-related increases in the incidences of DF were also noted in all groups given doses higher than 30 ppm.
Follicular adenomas and adenocarcinomas of the thyroid were found in the groups treated with 500, 250, and 60 ppm (Table 7) ; the combined incidences of benign and malignant follicular lesions were significantly increased in rats of the 500 ppm dose group. Mesotheliomas of the peritoneum were also observed in treated rats at doses higher than 30 ppm; again, the incidence in animals receiving 500 ppm was significant.
Although the RCT rates in high-dose males were somewhat lower than those in the previous carcinogenicity study, they were nevertheless significantly increased in a dose-related manner. The yield of RCTs in the 125-ppm group was significantly higher than that of controls, indicating that oral doses higher than 60 ppm may induce RCTs after long-term treatment. The incidence of mesotheliomas of the peritoneum was significantly increased only at a dose of 500 ppm in this study, in contrast to the significantly higher rates at both 500 ppm (59%) and 250 ppm (33%) in the former test. On the other hand, this experiment demonstrated elevated combined incidences of follicular adenocarcinomas and adenomas of the thyroid that were not observed in the previous study (6) . Although the incidence in rats given 250 ppm (15%, 3/20) was not significantly higher than controls, the observed dose-related increase seems to suggest that the thyroid follicular cells are also the target in KBrO3 carcinogenesis. The slight differences in results between the two studies are presumably because of variation in animal lots and the numbers of rats used. The virtually safe dose (VSD) values calculated for RCTs and DF on the basis of this experiment are discussed in the section "General Discussion and Sum-
Relationship between the Duration of Treatment and the Incidence of RCTs in Rats ( 7). Subsequently, an experiment was designed to ascertain the minimum induction time, minimum treatment period, and total dosage of KBrO3 required for the development of RCTs (17) . The dose of KBrO3 chosen for this study was 500 ppm in the drinking water because significant incidences of RCTs had already been observed at this dose level. The experimental protocol using 232 male F344 rats is illustrated in Figure 4 .
CONTINUED-TREATMENT PROTOCOL (COMPARISON BETWEEN GROUPS 1 TO 5 AND GROUPS 6 TO 10). Table 8 shows the results of the histopathologic diagnosis of Table 6 . Incidences and average numbers of renal cell tumors (RCT) and dysplastic foci (DF) in male F344 rats in the dose-response study. A few follicular adenomas of the thyroid were observed in rats given KBrO3 (groups 7 to 9). The combined incidences of follicular adenomas and adenocarcinomas of the thyroid were significantly increased in rats treated continuously for 104 weeks (group 10). A significant increase in the rate of peritoneal mesotheliomas was also found in the group continuously treated for 104 weeks (group 10). Two mesotheliomas were observed in rats exposed to KBrO3 for only 39 weeks. LIMITED DURATION PROTOCOL (COMPARISON BETWEEN GROUPS 5 OR 10 AND GROUPS 11 TO 14) . As shown in Table 8 The limited duration study thus revealed that the yields of preneoplastic and neoplastic lesions remained high, and therefore the effects of KBrO3 were not reversible. Furthermore, only 13 weeks of exposure was necessary to produce increases in the incidences of RCTs and mesotheliomas. Nonneoplastic changes in the kidney were not evident in limited duration groups, demonstrating that toxic lesions, in contrast, do not persist.
The mean total intake of KBrO3 in rats given a dose of 125 ppm for 104 weeks (5.3 g/kg) in the dose-response study was close to that of rats receiving a dose of 500 ppm for only 13 weeks (4.2-4.3 g/kg) in this study. However, the eventual incidence of RCTs was approximately 2-fold higher in the latter than in the former group (50% vs. 21%). This phenomenon was also noted in mice treated with 2-acetylaminofluorene (51, 52) . In this study much higher incidences ofboth liver and bladder tumors were observed in animals dosed for 9 or 12 months and sacrificed at 24 months than in groups receiving equivalent total doses spread over 18 or 24 months. Thus, higher doses of KBrO3 given for a shorter period of time appear more effective for producing a high yield of tumors than a lower dose given for a longer period.
It was concluded that the minimum induction time for the development of renal adenomas was between 13 and 26 weeks, and the minimum treatment period and 
0) Follicular adenoma and adenocarcinoma combined 7(37)* 3(15)
C-cell adenoma and adenocarcinoma combined 1 (5) 1 (5) 1 (4) 3 (13) 5 (25) 1 (5) 3 (19) Peritoneum, mesothelioma 15(75)t 3 (15) 2 (8) 4 (17) 3 (15) 0(0) 0(0) a Number of rats for which thyroids were histologically examined. *p < 0.05. tp < 0.001. total dose for the induction of renal adenomas and adenocarcinomas were less than 13 weeks and less than 4 g/kg body weight, respectively, when the rats were maintained thereafter on distilled water (DW) for 2 years. However, it is probable that the values for the true minimum treatment period and total dose will be smaller than 13 weeks and 4 g/kg body weight if experiments involving shorter exposure to higher doses of KBrO3 were performed. Long-Term Observation of Rats after a Single IG Administration. A total of 81 male F344 rats were given a single IG administration of KBrO3 at doses of 600, 300, or 0 mg/kg and were observed for 87 weeks (35) . In the group administered 600 mg/kg, a large renal tumor developed that was diagnosed as an adenocarcinoma. Three renal adenomas were also found in the same group. The final incidences of RCTs were 13.6% (4/41), 0% (0/20), and 0% (0/20), respectively, in groups given 600, 300, and 0 mg/kg. Considering the very low spontaneous rate of RCT development in rats, it appears probable that KBrO3 exerted the initiation activity for induction of the lesions, despite the fact that the incidence was not statistically significant.
Long-Term Oral Administration in Mice. A total of 50 female B6C3F1 mice were given KBrO3 at doses of 1000 or 500 ppm in the drinking water for 78 weeks, and then tap water for 26 weeks until sacrifice at week 104 (15) . Although body weight gain was markedly inhibited in the 1000-ppm group, the survival was comparable among groups. Daily intakes of KBrO3 were 119.8 and 56.5 mg/kg body weight/day in the animals given 1000 and 500 ppm, respectively. Although relatively high incidences of lung, liver, and lymph node tumors were observed in the 1000-ppm group, the incidences of these tumors were not significantly different from those of the controls.
A further study was conducted to ascertain the effects of 750 ppm KBrO3 administered orally for 88 weeks to groups of 27 male mice in B6C3F1, BDF1, and CDF1 strains (35) . This study also resulted in no statistically significant differences in growth rate or survival time between the treated and control groups. The intake of KBrO3 was in the range of 60 to 90 mg/kg body weight/ day for all three strains.
As shown in Table 9 , one renal adenocarcinoma was found in a B6C3F1 mouse treated with KBrO3. Also, a total of four renal adenomas developed in treated mice, and DF were found in more treated mice than controls of both B6C3F1 and BDF1 strains. There is a potential for KBrO3 to also induce RTC in mice. This is attributed to the fact that a) the spontaneous occurrence of RCT in mice is very low [for example, in B6C3F1 mice the incidences are reported to be 0.1% (3/2543) in males and 0.08% (2/2522) in females (53)], and b) the observed RCTs were morphologically quite similar to those induced by KBrO3 in rats. Furthermore, significant increases in the occurrence of adenomas of the small intestine in CDF1 mice and of adenomas of the liver in B6C3F1 were observed.
Long-Term Oral Administration in Hamsters. Groups of 20 male Syrian golden hamsters were given a KBrO3 supplement in their drinking water at concentrations of 2000, 500, 250, and 125 ppm for 89 weeks (11) .
No apparent differences were noted in the survival times. The mean final body weights of animals treated with 2000 ppm KBrO3 were significantly reduced, and the mean absolute and relative kidney weights in animals given 2000 or 250 ppm KBrO3 were significantly higher than controls. Renal adenomas developed in 1, 2, and 4 hamsters in groups given 250, 500, and 2000 ppm, respectively, for a total incidence of 7 in 75 treated animals (9.3%). RCTs were not observed in controls, and the structural and cellular morphologic characteristics of RCT, as well as DF found in the exposed hamsters, were quite similar to those induced in rats. Because the spontaneous development of RCT in hamsters is known to be extremely low (55), it is highly likely that the observed lesions, although of low incidence, were induced by KBrO3.
Subcutaneous Injection into Newborn Mice and Rats. KBrO3 was given at doses of 200, 100, 50, 25, and 12.5 mg/kg body weight to newborn ICR mice and at doses of 100, 50, 25, and 12.5 mg/kg body weight to newborn F344 rats, either as single (24 hr after birth) or 4 weekly SC injections until weanling (16) . All the surviving mice and rats were killed at weeks 78 and 82, respectively. (Figs. 5-7) . Adenocarcinomas were usually irregularly contoured as if two or more small nodules became aggregated. These tumors were mostly localized in the cortical areas, although occasionally they exhibited a deep downward growth from the cortex into the medulla. Most exhibited a solid growth pattern, but in some cases, they showed trabecular, tubular, or papillary patterns (Figs. 8 and  9 ). In some large adenocarcinomas, extensive areas of necrosis and hemorrhage were observed. The malignant tumor cells-like those in adenomas-were also polygonal in shape and demonstrated clear, granular, or dark cytoplasm. Mitotic figures were occasionally seen but nuclear pleomorphism was not apparent (Fig. 10) . Apparent infiltrative growth was observed in cases of grossly large tumors. A lung metastasis was found in one case in the rat carcinogenicity test.
Essentially, the histologic features of RCTs found in KBrO3-treated male hamsters and male mice were quite similar to those observed in KBrO3-treated rats. Dysplastic Foci. Focal tubular lesions that showed hyperplasia of the tubular lining epithelium, which often resulted in narrowing of the tubular lumina, were diagnosed as dysplastic foci (DF) throughout our studies (Fig. 11 ). Dilated tubules with multilayered and/or enlarged epithelial cells with a papillary growth pattern were also classified as DF (Fig. 12) . DF in our study seem to correspond to putative preneoplastic lesions described by others as atypical cell foci, pathologically changed tubules, focal areas of dysplastic tubular epithelium, small nodules, or dysplasia (8) .
Nonneoplastic Changes
Renal tubules in KBrO3-treated rats demonstrated various degenerative, necrotic, and regenerative changes. Numerous eosinophilic bodies were observed FIGURE 11 . Dilated tubular lesion demonstrating hyperplastic epithelium.
in the cytoplasm of proximal renal tubules in rats treated continuously with KBrO3 for 13 to 104 weeks. However, these changes were not evident in rats of the limited duration experiment, indicating that they are reversible. Hyaline casts in the tubular lumen, hyaline droplets, and brown pigments in the tubular epithelium were also commonly observed. Although these lesions were also found in control rats, they were more extensive in both degree and distribution in treated rats, especially in males. Vascular changes, which were observed in the rat study after feeding KBrO3-treated bread (49), were not evident in any organs. The transitional epithelium of the renal pelvis showed thickening, papillary hyperplasia, and growth, especially in treated males. Calcium deposits in the renal pelvis were also marked in rats showing the hyperplastic changes.
These nonneoplastic changes occurred to a lesser degree in hamsters and mice given KBrO3 than in rats. 
Initiation and Promotion
Assay for Promoting Potential for Kidney, Liver, and Urinary Bladder Tumorigenesis in the Rat
Although the carcinogenicity of KBrO3 in rats was definitely established by several experiments, it was thought necessary to test the promoting effects of this compound to better understand the mechanisms underlying its carcinogenic action and organ specificity (5) . N-Ethyl-N-hydroxyethylnitrosamine (EHEN) was used as an initiator for this purpose because this carcinogen is known as a potent initiator useful for determining the promotion potential of exogenous chemicals on kidney and liver tumorigenesis (56) (57) (58) .
A total of 128 male F344 rats were given EHEN orally for 2 weeks and then 500 ppm KBrO3 orally for the following 24 weeks. The kidney and liver were cut into 6 to 8 serial slices. The numbers of microscopic neoplastic lesions were counted, and the entire areas of the sections were measured with a semiautomatic image analyzer (TAS-plus, Leitz Wetzlar, West Germany). There were significantly increased incidences of DF and average numbers of both DF and RCT/cm2 in groups given KBrO3 after initiation as compared to values for animals treated with EHEN alone; therefore these findings clearly demonstrated enhancing activity of KBrO3 on kidney lesion development (Table 10) . No hyperplastic or neoplastic changes were observed in the renal pelvis or urinary bladder in any of the groups, and no significant differences in the incidences and average numbers of hyperplastic foci, neoplastic nodules, and hepatocellular carcinomas were found.
Recently, a very effective rapid bioassay system for rat hepatocarcinogenesis was developed, based on the two-stage carcinogenesis concept (59) . In this model rats were given a single dose (200 mg/kg) of diethylnitrosamine IP as an initiator and then fed KBrO3 in the diet (4000 ppm) for 6 weeks. A two-thirds partial hepatectomy was performed at week 3. As in the longterm experiment, KBrO3 showed no enhancing effect on hepatocarcinogenesis.
Dose-Response Studies on the Promoting Potential for Renal Tumorigenesis in the Rat
Dose-response studies using a total of 180 male F344 rats were undertaken to clarify whether a threshold level of KBrO3 treatment exists for promotion of renal tumorigenesis (8) . The promoting effect of KBr was also tested since KBrO3 is easily degraded to KBr during the baking process. Experimental protocols were similar to those used in the previous promotion study (5) .
The mean numbers of DF/cm2 were found to be significantly increased in a dose-related manner in rats treated with > 30 ppm KBrO3 (Table 11) . A parabolic curve was obtained by exponential regression analysis when the numbers of DF/cm2 were plotted against the 
Assay of Two-Stage Esophageal Carcinogenesis in the Rat
Groups of 15 male F344 rats were given dibutylnitrosamine (DBN) at a dose of 500 ppm orally for 4 weeks as the initiation step and then administered 500 ppm KBrO3 orally for 32 weeks (Kurokawa, unpublished data). The incidences of neoplastic lesions of the esophagus and other GI tract organs in rats given KBrO3 after initiation were not significantly increased as compared to control values.
Mutagenicity Microbial Assays
In Japan microbial testing of KBrO3 was conducted simultaneously in several laboratories under the cooperative program on short-term assays (2) . Using Salmonella typhimurium TA100, KBrO3 was found to be weakly positive at a concentration of 3 mg/plate after metabolic activation. However, the compound proved negative in TA98, TA1535, TA1537, TA1538, E. coli WP2try-and E. coli WP2try-his-with or without metabolic activation (2, 61, 62) . Similarly, in the USA no mutagenic activity could be demonstrated for KBrO3 in Salmonella typhimurium (strains not specified) or Sarcina cerevisiae (Litton Bionetics, personal communication).
Very recently, microbial tests were reconducted in our laboratory (Kurokawa, unpublished data). Weak mutagenic activities were again demonstrated in TA100 at doses of 2 to 4 mg/plate with or without metabolic activation. KBrO3 was also mutagenic in TA102 and TA104, strains which are sensitive to chemicals that generate active oxygen radicals (63) in the presence of metabolic activation (Fig. 14) . KBr was negative in both TA98 and TA100.
Microbial assays of NaBrO3 and silver bromate (AgBrO3) were also conducted in strains TA 97, 98, 100, and 102 in order to ascertain the general mutagenic potential of bromate (BrOi3) compounds. Both NaBrO3 and AgBrO3 proved negative in all strains tested at the maximum levels of 5 mg/plate and 25 ,ug/plate, respectively (Kurokawa, unpublished data). The very low solubility of AgBrO3 might be the reason for negative data.
The results of Rec assays on KBrO3 using Bacillus subtilis (17Arec+, 45Trec+) were also negative with or without metabolic activation (2).
Chromosome Aberration Tests
The rates of chromosome aberrations in Chinese hamster lung (CHL) cells treated with KBrO3 were found to be significantly higher than in controls at dose ranges of 0.0625 to 0.25 mg/mL, in a dose-dependent manner, without metabolic activation (2, (64) (65) (66) (Table 12) . Mainly chromatid type breaks and exchanges were induced. The value D20, representing the dose at which aberrations were detected in 20% of metaphase cells, was calculated to be 0.071 mg/mL. Therefore, the clastogenic activity of KBrO3 was considered to be relatively strong (66) .
Chromatid breaks were also induced in cultured Chinese hamster DON-6 cells by the addition of 5 x 10-4 M (0.0835 mg/mL) KBrO3 (67) . In vivo clastogenic activity of KBrO3 was further examined in bone marrow cells of male Long-Evans rats administered KBrO3 by IP and oral routes. The incidences of aberrant metaphase cells were significantly increased, reaching a maximum of 10.5% at 18 hr (IP, 250.5 mg/kg body weight) and of 10.8% at 18 hr (oral, 334.0 mg/kg body weight). On the contrary, an IP injection of heat treated KBrO3 (190°C or 230°C for 20 min) at a dose of 167 mg/kg body weight had no effect on numbers of aberrant cells (68) .
KBr was positive in the chromosome aberration test at doses greater than 4 mg/mL, inducing chromatid gaps, breaks, and exchanges (62, 66) . However the D20 of KBr (3.7 mg/mL) was much higher than that of KBrO3.
Micronucleus Tests
Micronucleated polychromatic erythrocytes were induced in male ddY mice in a dose-dependent manner when KBrO3 was administered at doses higher than 25 and 100 mg/kg body weight by IP and oral routes, respectively (69) . Among 47 compounds tested, including 39 synthetic and natural food additives, only KBrO3 was positive by both IP and oral application. In contrast, 
Silk Worm Test
Mutagenicity testing using silk worms was reported to be negative (2) .
Absorption, Distribution, Excretion and Metabolism
In Vivo Studies
Male Wistar rats were given KBrO3 IG at a dose of 50 mg/kg body weight as BrO 3, and the levels of BrO 3 and Br-in various organs were examined (72) . Each organ was homogenized in water and freeze-dried and then assayed using ion chromatography method (28) . As shown in Table 13 , approximately 30% of BrO 3was detected in the urine 24 hr after the treatment. The levels of Br-were increased significantly in the plasma, RBC, kidney, pancreas, stomach, small intestine, and urine. Thus it is evident that the BrO 3given orally was absorbed and partly excreted, unchanged in the urine; the remainder was at least partly reduced to Br-. However, it was not clear whether the increased Br-all originated via degradation of BrO3 or if redistribution in the body might play a role. Also it is unknown whether BrO 3 or Br-was not totally extracted because of binding with insoluble fractions, proteins, etc., during sample preparation or for other reasons. Clarification of these points will require further study including the development of a microassay for biological specimens.
Time-related changes in the levels of BrO3 after the IG administration of KBrO3 (100 mg/kg body weight) are illustrated in Figures 15 and 16 . It is evident that BrO3 was rapidly absorbed and degraded in the stomach, small intestine, plasma, and urine within 2 to 4 hr. Dose-response studies further revealed that no BrO3 was detectable in the urine of rats given KBrO3 at doses lower than 2.5 mg/kg body weight. However, at doses higher than 5 mg/kg body weight, a dose-related increase in the levels of BrO 3 excreted into the urine was apparent (Fig. 17) . Therefore, it is probable that BrO3 could have exerted direct effects on the renal tubular epithelial cells at doses higher than 5 mg/kg; this finding could help to explain the mechanism of carcinogenicity of this compound in the kidney.
In Vitro Studies
The decomposition of BrO 3 in various rat tissues was examined in vitro to cast light on the mechanism of in vivo biodegradation (73) .
As shown in Table 14 , no degradative activity was levels after heat treatment at 100°C for 5 min. Subsequently, supernatants from tissues showing degradative activity were fractionated by gel filtration. High and low molecular weight liver fractions-the latter containing GSH and other -SH compounds-were examined. The activity of the former disappeared after heating, whereas that of the latter was retained. Hemolyzed RBCs, kidney, small intestinal mucosa, and stomach tissues could be also fractionated to give two similar components.
SH compounds such as cysteine, glutathione (GSH), and ergothioneine were found to have BrO3 degradative activity (Table 15 ) and simultaneous analysis of residual BrO-3 and yielded Br-in the presence of GSH revealed a near stoichiometric response, as shown in Figure 18 . From these data it is highly probable that GSH is intimately involved in the degradation of BrO 3 . Moreover, Br-is yielded in the GSH-mediated reaction that corresponds well to the fact that Br-concentration increased in organs and urine of rats after an oral administration of BrO 3 .
Studies on the Mechanism of KBrO3 Carcinogenesis Toxicological Studies
Lipid peroxide (LPO) in tissues is mainly generated by the oxidative deterioration of cell membrane polyunsaturated fatty acids by active oxygen species (74). thione.
GSH ( mM )
Stoichiometric degradation of BrO3-to Br-by glutaThe protective role of cysteine and GSH and the deleterious influence of diethylmaleate (DEM), a GSH-depleter, on cellular oxidative damage and LPO formation are well known (75) .
Lipid Peroxidation in the Kidney. Changes in the levels of LPO in the kidney of male F344 rats, CDF1, BDF1, and B6C3F1 mice, and Syrian golden hamsters were studied after IV administration of KBrO3. Alteration in levels of malondialdehyde (MDA, nmole/g wet tissue) was used as an index of LPO according to the procedure using thiobarbituric acid (TBA) (76) . The TBA method has been used extensively to measure LPO levels in the liver, and its recent application to the kidney allowed dose-dependent and time-dependent changes to be shown in response to exogenous chemicals (77) (78) (79) .
As illustrated in Figure 19 , LPO levels were significantly increased in rats given KBrO3 without them receiving accompanying cysteine treatment. However, when the rats were also given IP injections of cysteine Figure 20 shows the time-dependence of LPO elevation in rats receiving a single KBrO3 treatment of 120 mg/kg body weight. After an initial significant decrease at 6 hr, the levels of LPO were found to be significantly increased at 12, 24, and 48 hr. However, LPO levels in the kidneys of mice and hamsters did not demonstrate any equivalent increase at this dose level of KBrO3. Therefore, dose-and time-related significant increases in the levels of LPO were apparent in the kidneys of male rats given KBrO3 at a dose of 77 mg/kg body weight or above. These overall data strongly show a particularly strong potential for oxidative damage in the kidney of rats; this finding might explain the observed species differences in susceptibility to KBrO3 carcinogenicity to the kidney. Effects of GSH, Cysteine, and DEM Treatment on Mortality. In rats given KBrO3 IV without GSH treatment, all animals died within 3 days at a dose as low as 108 mg/kg (18) . On the other hand, when animals were also treated with GSH, mortality was greatly reduced and no animals died at doses lower than 214 mg/kg KBrO3 (Table 16 ). Similar results were observed with cysteine treatment (Table 17) , and-again in contrast-when rats were pretreated with DEM (Table  18) , mortality was significantly increased.
Changes in Serum Biochemistry. As shown in Table 19 , the levels of NPN, BUN, and creatinine were significantly increased in a dose-related manner in male F344 rats after a single IV administration of KBrO3 (18) . Elevation was first observed between 3 and 6 hr, peaking at 24 hr before returning to normal at 48 hr (Table 20) . However, the increase in values for these parameters was significantly inhibited in rats treated with GSH or cysteine (Table 21) . DEM treatment had the opposite effect, bringing about a significant further elevation over KBrO3-alone levels (Table 22 ). (80) (81) (82) . It was therefore considered of interest to determine the relationship between 8-OH-dG formation in tissue DNA and the carcinogenic potential ofan oxidizing agent like KBrO3 (19) .
As shown in Figure 21 , Retention time (min) FIGURE 21. Analysis of 8-OH-dG using an HPLC-ECD system. A) untreated rat kidney DNA, B) rat kidney DNA, 24 hr after IG KBrO3 treatment.
normal levels was observed (Fig. 22) (33, 34) ; the actual exposure was therefore negligible. In contrast, KBrO3 is fairly stable when dissolved in water (6) , and the concentrations administered were considered as the actual dose levels ingested by the animals.
The carcinogenicity of KBrO3 was clearly established in F344 rats after long-term oral administration in the drinking water at doses of 500 and 250 ppm (6) , with significantly higher incidences of RCTs in both sexes and mesotheliomas in males being induced. Subsequent dose-response studies (14) confirmed the generation of RCTs even at the 125 ppm level, and these further demonstrated induction of thyroid follicular adenomas and adenocarcinomas in males given 500 ppm. It has therefore been concluded that tubular epithelial cells of the kidney, mesothelial cells of the peritoneum, and follicular epithelial cells of the thyroid are target cells for KBrO3-carcinogenesis.
While the incidences of RCTs in mice (3 strains) and hamsters were relatively low after long-term oral treatment (11, 5) , the fact that the RCTs spontaneous develop in these species is very rare suggests that KBrO3 might possess cross-species kidney carcinogenic potential. The weak response might be related to the finding that resistant species are less susceptible than rats to the toxicity of KBrO3 .
In most cases current chronic bioassays are incapable of distinguishing between complete carcinogens, incomplete carcinogens (pure initiators), and promoters (83) . There is no doubt that KBrO3 can act as a mutagen from the results of both chromosome aberration and micronucleus tests, although the activity is only very weak in some microbial assays (61) . After a single IG (600 mg/ kg body weight) administration of KBrO3 in vivo, RCTs were observed in 4 of 41 rats after 87 weeks (Kurokawa, unpublished data). This fact, taken together with the significant eventual rate of RCT induction (50%) when the compound was administered in drinking water at 500 ppm for only 13 weeks (17), strongly suggests a positive initiating action of KBrO3.
Furthermore, a promoting action of KBrO3 in renal tumorigenesis was clearly evident in the two-stage carcinogenesis model investigated (5) . The threshold level of KBrO3 for promotion of RCTs appeared to be 15 to 30 ppm in the drinking water (8) , although no effects on tumors of the liver (5,59), skin (7), or GI tract (Kurokawa, unpublished data) were observed. The available data suggest that KBrO3 should be classified as a complete carcinogen, possessing both initiating and promoting activities for the rat kidney.
A close similarity between KBrO3-related toxicological findings in experimental animals and man has been noted. Disturbance of functions accompanied with the histopathological changes in the kidney and the inner ear have been observed in common in acute KBrO3 intoxication (39, 41) . It should further be borne in mind that the morphological features of RCTs induced by KBrO3 in rats, mice, and hamsters are very similar to those observed in humans, being essentially the same as those caused by application of other renal carcinogens (6, 14) . The nephrotoxic action of KBrO3 in animals was found to be reversible in the subacute toxicity (10) and the limited duration protocol experiments (17) . In addition, RCTs and DF were induced by KBrO3 in rats at doses < 125 ppm, in which chronic nephropathic changes were only very slight. Therefore, the carcinogenic action of KBrO3 is not dependent on its nephrotoxicity.
Although the occurrence of periarteritis in the pancreas and accelerated aging pathology of the adrenals were observed in rats fed on bread made from flour treated with KBrO3 alone or with KBrO3 and other oxidizing chemicals (49, 50) , these findings seem to be the effects of the bread diet, since they were not observed after oral administration of KBrO3 even at high dose levels.
Mechanisms
The oxidizing properties of KBrO3 are the reasons for its use as a food additive and industrial chemical. Recently, carcinogenic and promoting potentials of several oxidizing chemicals have been revealed by various in vivo and in vitro studies. In mouse skin carcinogenesis, for example, benzoyl peroxide was found to be a potent promoter (84) (85) (86) and weak complete carcinogen (7) . The same compound is also suspected as a causative agent for skin cancer in man (87, 88) . Hydrogen peroxide, lauroyl peroxide, decanoyl peroxide, cumene peroxide, and sodium chlorite were all demonstrated to be promoters in the skin system, albeit relatively weak (7, 84, 89) . Hydrogen peroxide given orally proved to be a carcinogen inducing duodenal tumors in mice (90) and a promoter for the development of intestinal tumors (91) and forestomach papillomas in rats (92) . Disturbance of cellular communication, activation of protein kinase C and H-ras oncogene, and induction of DNA strand breaks by oxidizing chemicals have also been recently reported (93) (94) (95) (96) (97) .
It is generally accepted that the carcinogenic and promoting action of these compounds is caused by generated active oxygen species (98) (99) (100) (101) . Furthermore, studies on oxidant chemicals such as paraquat (102) , ozone (103) , and NOx (104) , have clearly demonstrated that they all induce LPO in their target organs, and the induction of LPO and clastogenic activity are now considered to be the main factors underlying the carcinogenic and/or promoting effects shown by these agents.
Based on the oxidizing property of KBrO3, the levels of kidney LPO were examined in animals administered this compound (18) . The findings of significant increases in kidney LPO levels in both a dose-dependent and timedependent manner in rats, but not mice or hamsters, seem to imply a possible relationship between LPO formation in the kidney and the species differences in the renal toxicity and carcinogenicity of KBrO3.
In addition, a protective role of cysteine and GSH (19) . Significantly increased levels of 8-OH-dG were observed after either a single IG dose or continuous oral administration of KBrO3 in the kidney, but not in the liver. In contrast, the noncarcinogenic oxidizing agents sodium chlorite and sodium hypochlorite had no effect on 8-OH-dG formation (19) . These results are therefore in agreement with the hypothesis that formation of 8-OH-dG in tissue DNA is closely related to organ specificity in carcinogenesis. On the other hand, incubation of KBrO3 directly with DNA in vitro did not result in 8-OH-dG generation, although it did increase the level of 8-OH-dG produced by methyl linolenate.
In summary, we suggest that KBrO3 produces LPO from unsaturated fatty acids in vivo through its oxidizing actions, and the genotoxic activity of KBrO3 may be the result of DNA damage by LPO and/or active oxygen radicals generated in the process of LPO formation. Recently we found that hydroxy radicals were generated in vitro by KBrO3 using electron spin resonance (Kurokawa, unpublished data) .
Meanwhile, further research will be needed to clarify the mechanism of action of KBrO3 for induction of peritoneal mesotheliomas and thyroid follicular cell tumors.
Risk Assessment, Regulatory Status, and Future Prospects Toxicologic studies of KBrO3 were reviewed by the JECFA in 1964 (22) and 1979 (24) . As a result, it was evaluated as one of the safe-to-use food additives and listed within Class A (1). However, since more recent studies provided strong evidence of its carcinogenicity, it was decided at a 1983 meeting that the previous acceptance for the treatment of flour used for baking products should be changed to a temporary acceptance with a maximum treatment level of 75 mg KBrO3 per kg of flour, provided that bakery products prepared from such treated flour could be shown to contain only negligible residues of KBrO3 (25) . No acceptable level was allocated for use in other foods. In 1982, the Ministry of Health and Welfare of Japan had already decided to lower the maximum treatment level of KBrO3 for flour from 50 mg/kg to 30 mg/kg. At the same time, the use of KBrO3 for the improvement of fish paste products was banned (26) .
The residual levels of KBrO3 at currently acceptable flour treatment doses have been reported to be negligible in bread (32, 34) . In fact, no carcinogenic action was detectable after feeding bread-based diets in longterm bioassays (49, 50) . Therefore, in consideration of the fact that almost all KBrO3 added to the flour is converted to KBr during the bread-baking process (34) , future concern should be directed toward the toxicological effects of KBr in humans (105); so far, no promoting and only weak mutagenic activities have been demonstrated for this compound (8, 62) .
Recently the concept of a virtually safe dose (VSD) has been proposed as a useful parameter for risk assessment, especially for genotoxic carcinogens (106, 107) . The VSD values, based on data for RCTs from the dose-response studies (Table 6 ) estimated by different models at a risk level of 106, are listed in Table  23 (12) (13) (14) . The VSD value of 0.950 ppm KBrO3 was obtained for RCTs by the Probit model with an independent background, with the largest p-value (0.898), which indicates a good fit.
In the similar evaluation process to IARC, which has been adopted by the U.S. Environmental Protection Agency (EPA) (108) , this compound will probably be included in Group B2, because of sufficient evidence from animal studies and no data from epidemiologic studies. Alternatively, KBrO3 can be classified as a compound showing "clear evidence of carcinogenicity," ac- cording to the categorization used by the National Toxicology Program (109) . Although active oxygen radicals have been anticipated to play an important role in the carcinogenic process on the basis of various in vitro studies (110) , the numbers of in vivo models in which this hypothesis could be confirmed are limited. In the case of KBrO3, there is increasing evidence to suggest that active oxygen species are actually involved in its carcinogenic and toxic effects. Therefore we believe that KBrO3 could provide a key for future investigation of this intriguing area of carcinogenesis research (111) .
Conclusion
KBrO3 exerts nephrotoxic and ototoxic effects in experimental animals as well as in man. KBrO3 is a genotoxic carcinogen inducing renal cell tumors, mesotheliomas, and thyroid follicular cell tumors in rats. KBrO3 is a complete carcinogen having both initiating and promoting activities for the development of renal cell tumors. It is highly probable that active oxygen radicals are involved in the demonstrated carcinogenic and toxic effects. Commercial bread made from flour treated with KBrO3 is not carcinogenic in experimental animals, probably because almost all of the KBrO3 is converted to KBr during the bread-baking process. KBrO3 is a useful new compound for analyzing the roles played by active oxygen radicals in carcinogenesis, both in vivo and in vitro.
